ACGT is proud to announce two scientists that are recipients of the ACGT Young Investigator Grants:
Dr. Marco Gallo of the University of Calgary and Dr. Greg Delgoffe of the University of Pittsburgh. Each grant is for $250,000 over 2 years and brings ACGT total to nearly $27 million to cancer research and treatment. ACGT is supporting Dr. Gallo’s research into the cellular anomalies in glioblastoma brain cancer and Dr. Delgoffe’s research into metabolically reprogramming tumor-specific T cells for treating solid tumors including melanoma. For more information about our fellows, click here.